Variant report
Variant | nsv3862 |
---|---|
Chromosome Location | chr3:68608012-68653563 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs13321458 | chr3:68610030-68610031 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs188345845 | chr3:68610170-68610171 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs532539999 | chr3:68610174-68610175 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs181822206 | chr3:68610216-68610217 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs563234387 | chr3:68610245-68610246 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs17246157 | chr3:68610324-68610325 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs548825640 | chr3:68610350-68610351 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs568689407 | chr3:68610365-68610366 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs185701658 | chr3:68610429-68610430 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs1511888 | chr3:68610451-68610452 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs17047842 | chr3:68610525-68610526 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs570351603 | chr3:68610567-68610568 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs530741728 | chr3:68610571-68610572 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs34987289 | chr3:68610573-68610574 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs190702106 | chr3:68610598-68610599 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs569963223 | chr3:68610627-68610628 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs17047843 | chr3:68610632-68610633 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs17047845 | chr3:68610660-68610661 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs186986684 | chr3:68610663-68610664 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs17047847 | chr3:68610677-68610678 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs190087237 | chr3:68610699-68610700 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs181422632 | chr3:68610714-68610715 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs9835386 | chr3:68610847-68610848 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
24 | rs185226342 | chr3:68610872-68610873 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs113698920 | chr3:68610916-68610917 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs576780415 | chr3:68610966-68610967 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs189980498 | chr3:68611016-68611017 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs562219830 | chr3:68611077-68611078 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs527937525 | chr3:68611085-68611086 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs547169943 | chr3:68611087-68611088 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs376740673 | chr3:68611122-68611123 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs564244420 | chr3:68611187-68611188 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs532769662 | chr3:68611195-68611196 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs549722022 | chr3:68611197-68611198 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs140264378 | chr3:68611199-68611200 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs145286401 | chr3:68611208-68611209 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs528796299 | chr3:68611211-68611212 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs535326409 | chr3:68611276-68611277 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs545654765 | chr3:68611278-68611279 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs548868022 | chr3:68611290-68611291 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs565535414 | chr3:68611294-68611295 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs182340230 | chr3:68611298-68611299 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs553956391 | chr3:68611323-68611324 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs137881024 | chr3:68611324-68611325 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs539569180 | chr3:68611347-68611348 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs556484665 | chr3:68611367-68611368 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs576510189 | chr3:68611370-68611371 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs188651889 | chr3:68611437-68611438 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs370569976 | chr3:68611445-68611446 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs562412533 | chr3:68611449-68611450 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Breast cancer | 17133270 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16608533 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 19490591 | CNVD |
Autism | 18414403 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Metastatic melanoma | 17975146 | CNVD |
Breast cancer | 21509527 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Autism | 22102821 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Mental retardation | 21062444 | CNVD |
Prostate cancer | 17217626 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Alzheimer''s disease | 22166940 | CNVD |
Mental retardation | 20848658 | CNVD |
Breast cancer | 17142309 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Breast cancer | 21364760 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Cancer | 20164919 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:68610000-68612000 | Enhancers | Fetal Lung | lung |
2 | chr3:68620000-68620600 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr3:68620600-68620800 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
4 | chr3:68620800-68622400 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
5 | chr3:68622400-68622600 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
6 | chr3:68624400-68625000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
7 | chr3:68624600-68625200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
8 | chr3:68628200-68628400 | ZNF genes & repeats | H1 Derived Mesenchymal Stem Cells | ES cell derived |
9 | chr3:68646000-68649000 | Weak transcription | Aorta | Aorta |
10 | chr3:68646800-68647600 | Enhancers | Fetal Stomach | stomach |
11 | chr3:68647000-68647400 | Enhancers | Colon Smooth Muscle | Colon |
12 | chr3:68649000-68649600 | Enhancers | Aorta | Aorta |
13 | chr3:68649400-68649600 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
14 | chr3:68649600-68652400 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
15 | chr3:68652200-68652800 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
16 | chr3:68652400-68653000 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
17 | chr3:68652800-68657200 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |